SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-024543
Filing Date
2024-08-05
Accepted
2024-08-02 19:06:41
Documents
16
Period of Report
2024-08-02
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K zvra20240802_8k.htm   iXBRL 8-K 41076
2 EXHIBIT 99.1 ex_707898.htm EX-99.1 14465
7 picture3.jpg GRAPHIC 5788
  Complete submission text file 0001437749-24-024543.txt   203178

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zvra-20240802.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zvra-20240802_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zvra-20240802_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zvra-20240802_pre.xml EX-101.PRE 11584
18 EXTRACTED XBRL INSTANCE DOCUMENT zvra20240802_8k_htm.xml XML 2850
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 241172699
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)